Pharmaceutical Drugs and Their Impact on the Triple Aim

  • October 25, 2016
  • 3:00 PM – 4:00 PM ET
  • Online
about

Pharmaceutical drugs have a profound and complex impact on the U.S. healthcare system’s pursuit of the Institute for Healthcare Improvement’s Triple Aim. Consider that two-thirds of physician office visits involve drug therapy and nearly 60% of Americans have taken a prescription drug in the past month—at an annual cost of over $300 billion!

But it’s not just utilization and high cost. Prescription drugs, over-the-counter drugs and nutritional supplements are overused, underused and misused. Their costs are unregulated, incentives are misaligned, access is not universal, and there are multiple layers of administration involved at every stage from manufacturing to consumption.

The webinar will address the issue of how to align the cost of drugs with the value they provide. It will also address how to make sure that pharmaceutical drugs achieve their intended use.

Attendees will be able to:

  • Understand the most urgent issues in pharmacy the healthcare industry faces and how they relate to the Institute for Healthcare Improvement’s Triple Aim.
  • Recognize where they can address issues of prescription medication overuse, underuse and misuse.
  • Identify opportunities among multiple stakeholders in healthcare to improve value related to pharmacy.

Who should attend: Commercial health plans, provider-owned health plans, government agencies, Medicare Advantage plans, Medicaid Managed Care plans


Speakers:


Steve DelarondeSteve Delaronde,Director of Analytics, Populations and Payment Solutions, 3M Health Information Systems
Steve Delaronde is the director of analytics for Populations and Payment Solutions at 3M Health Information Systems. He oversees the analysis and interpretation of healthcare data for 3M clients. He has over 20 years of experience in health services managing the development and delivery of clinical, operational and financial outcomes for healthcare payers and providers. Prior to joining 3M, Steve specialized in health services research, analytics and presentations, and publications related to medical management, behavioral health and musculoskeletal health conditions among commercially-insured, Medicare and Medicaid populations.

Steve is an adjunct professor at the University of Connecticut where he also earned a Master of Public Health and Master of Social Work.